Trade QNRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) is trading at US$6.96, up 34.92% today as of Aug 28, 10:30 EDT. The company has a market capitalisation of US$11.19M. Over the past 52 weeks, QNRX has traded between US$3.25 and US$41.80. On Syfe you can trade QNRX with $0 commission and add it to your watchlist.
| Previous close | US$5.16 |
|---|---|
| Market cap | US$11.19M |
| 52-week range | US$3.25 – US$41.80 |
| Volume | 33.77K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Year: 2021
Quoin Pharmaceuticals Says US FDA Clears Phase 2 Trial of QRX003 in Peeling Skin Syndrome
Jul 9, 1:42 PM · MT Newswires
Quoin Pharmaceuticals Gets US Notice of Allowance for Netherton Syndrome Patent Application
Jun 30, 1:19 PM · MT Newswires
Top Premarket Gainers
Jun 24, 11:06 AM · MT Newswires
Quoin Pharmaceuticals' Potential Skin Disease Treatment Receives US Name Approval
Jun 23, 12:58 PM · MT Newswires
Quoin Pharmaceuticals' Skin Disorder Drug Receives Orphan Drug Designation in Japan
Jun 4, 1:03 PM · MT Newswires
Stay on top of QNRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
